AI Hallucination Research › Regulators › Major advanced economies › US › FDA › PROPOSED-BEMOTRIZINOL-SUNSCREEN-OTC-MONOGRAPH

Proposed Administrative Order, Bemotrizinol as New Active Ingredient for OTC Sunscreen Monograph

Food and Drug Administration (FDA) · published 2025-12-11

Last updated 14 Jun 2026 · Full ledger: Hallucination Register · Parent: FDA

0
Findings live
0
AI subjects
0
Citation issues
0
Dominant mode count
Research Pending Awaiting research outcome
Hallucination Shape
(0 Response Hallucination + 0 Citation Hallucination = 0 Hallucination findings)

Response Hallucination Modes (0 failures)

Misstated Rule 0 Outdated 0 Misattributed 0 Inference Drift 0

Citation Hallucination Modes (0 failures)

Fabricated 0
Pretextual 0
Contradictory 0
Hover any mode chip for definition · methodology

Hallucination findings

No published hallucination findings yet for this regulation. Research is queued or in progress.
← All regulations for FDA

Every finding on this page compares an AI subject's account of the rule against the regulator's verbatim text from the regulator's own portal. Both are linked. Each delta, its root causes, and impact analysis are documented and published with immutable Citation IDs.